Sperzel John J III 4
4 · T2 Biosystems, Inc. · Filed Feb 28, 2022
Insider Transaction Report
Form 4
Sperzel John J III
DirectorSee Remarks
Transactions
- Exercise/Conversion
Common Stock
2022-02-24+333,333→ 333,333 total - Exercise/Conversion
Restricted Stock Units
2022-02-24−333,333→ 666,667 total→ Common Stock (333,333 underlying) - Tax Payment
Common Stock
2022-02-24$0.45/sh−141,560$63,532→ 191,773 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]141,560 shares of common stock were automatically withheld at vesting to cover required tax withholding.
- [F3]On February 24, 2021 the reporting person was granted 1,000,000 RSU's that vest in three equal installments commencing on February 24, 2022.